Citigroup Maintains Neutral on RXO, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 50.6%

Neg 0% Neu 0% Pos 50.6%

Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $24 to $30.

Comments

No comments yet. Be the first!